SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001393905-20-000265
Filing Date
2020-08-27
Accepted
2020-08-26 18:37:38
Documents
7
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A rtsl_10ka.htm 10-K/A 184826
2 DESCRIPTION OF SECURITIES OF THE REGISTRANT rtsl_ex41.htm EX-4.1 12519
3 RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. 2018 STOCK PLAN rtsl_ex101.htm EX-10.1 17690
4 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT DATED JUNE 25, 2020 BY AND BETWEE rtsl_ex104.htm EX-10.4 12296
5 SUBSIDIARIES OF THE REGISTRANT rtsl_ex211.htm EX-21.1 2568
6 CERTIFICATION rtsl_ex311.htm EX-31.1 3453
7 CERTIFICATION rtsl_ex312.htm EX-31.2 3107
  Complete submission text file 0001393905-20-000265.txt   237694
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-55018 | Film No.: 201138524
SIC: 2834 Pharmaceutical Preparations